Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
07:16pm, Tuesday, 28'th Oct 2025
Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
04:00am, Friday, 24'th Oct 2025
MILAN, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer Company in immuno-oncology, and ANEMOCYTE, a leading provider of advanced therapy and nucleic acids solutions, today
Ginkgo Bioworks to apply its RNA construct design expertise to develop long-lived, tissue-specific, and highly potent in vivo CAR therapies for autoimmune diseases BOSTON , Oct. 23, 2025 /PRNewswire/
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
07:15pm, Wednesday, 22'nd Oct 2025
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78, marking a -2.67% move from the previous day.
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
08:05am, Tuesday, 21'st Oct 2025
Publication includes complete data for all participants (n=39) up to week 72, further demonstrating durable and tolerable expression of DMAbs Effective target binding and confirmed functional activity
CAMBRIDGE, United Kingdom and NEW YORK, October 13, 2025 - Artios Pharma Limited ("Artios"), a biopharmaceutical company committed to realizing the
Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note
07:16pm, Thursday, 09'th Oct 2025
Ginkgo Bioworks Holdings, Inc. (DNA) reached $15.24 at the closing of the latest trading day, reflecting a -5.28% change compared to its last close.
Ginkgo Bioworks Holdings, Inc. (DNA) Advances While Market Declines: Some Information for Investors
07:16pm, Tuesday, 23'rd Sep 2025
The latest trading day saw Ginkgo Bioworks Holdings, Inc. (DNA) settling at $12.35, representing a +2.66% change from its previous close.
America Has A New No. 1 Beer — And It's Got Bud Light DNA
06:10pm, Tuesday, 23'rd Sep 2025
Beer giant Anheuser-Busch InBev BUD can once again claim the title of making the bestselling beer in America, but this time it's not Bud Light that came out on top. Here's a look at the company's late
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
08:00am, Thursday, 04'th Sep 2025
BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks announced a series of new initiatives to accelerate the application of artificial intelligence in biologics drug discovery.
McDonald's CEO Chris Kempczinski on extra value meals: It's in the McDonald's DNA
09:02am, Tuesday, 02'nd Sep 2025
McDonald's CEO Chris Kempczinski joins 'Squawk Box' to discuss the launch of the new extra value menu, health of the consumer, cost pressures facing franchisees, the tax on tip debate, growth outlook,
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
04:05pm, Friday, 29'th Aug 2025
BOSTON , Aug. 29, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today released the following notice: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION WEINING HU, deriv
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
08:52am, Monday, 25'th Aug 2025
SECAUCUS, N.J. , Aug. 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA)
BOSTON , Aug. 20, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that its Datapoints offering has ente
Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average
10:31am, Wednesday, 13'th Aug 2025
After reaching an important support level, Ginkgo Bioworks Holdings, Inc. (DNA) could be a good stock pick from a technical perspective. DNA surpassed resistance at the 50-day moving average, suggesti
